Document Type


Publication Date



This is the postprint version of the authors article published in Skinmed, 2020, Volume 18, Issue 3, Pages 143-144.

The final published version of the article can be found at the journal website,

Copyright: Pulse Marketing & Communications, LLC


The absurd edicts initially issued by several governors, including those of Michigan and New York, prohibiting physicians from ordering hydroxychloroquine for patients suspected of or diagnosed with COV-19 are reprehensible. Their reasoning is beyond the pale.

Hydroxychloroquine was first approved by the FDA in 1955 and has a remarkable safety record in its use as a preventative for malaria and in the treatment of several immunologic and/or light induced diseases. Its use came about serendipitously, and its mechanism of action is unclear, but the fact remains that it seems to work.

PubMed ID


Included in

Dermatology Commons